Table 1.
Experimental groups.
| Groups | n | Antileukinate administration | TST, min | GIT, min |
|---|---|---|---|---|
| A | 6 | 2 doses of 10.0 mg/kg/d, bolus injection; im 24 h before and immediately after surgery | 140.3 ± 7.4 | 109.7 ± 3.6 |
| Cont-A | 6 | None* | 130.8 ± 7.9 | 104.0 ± 7.6 |
| B | 8 | Continuous, ip 10.0 mg/kg/d, days 0 to 7 | 140.6 ± 24.5 | 113.3 ± 24.0 |
| Cont-B | 8 | None* | 138.8 ± 17.6 | 107.3 ± 15.2 |
*
Each control group was given PBS in the same manner as its respective treated group. im, intramuscular; ip, intraperitoneal using micro-osmotic pumps; TST, total surgical time (from beginning of thoracotomy to end of surgery); GIT, graft ischemic time (from donor lung flush to reperfusion).